144 results on '"Schwartz, Marc"'
Search Results
2. Quality of Life for Patients with Sporadic Small Vestibular Schwannomas Following Middle Fossa Craniotomy
3. Pharmacogenomic testing in oncology: a health system's approach to identify oncology provider perspectives
4. Bridging Therapy in Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Receiving Standard of Care Brexucabtagene Autoleucel: Results from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA)
5. Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease
6. Venetoclax is safe and tolerable as post-transplant maintenance therapy for AML patients at high risk for relapse
7. The Effect of Immediate Microsurgical Resection of Vestibular Schwannoma on Hearing Preservation
8. Management of Neurofibromatosis Type 2-Associated Vestibular Schwannomas
9. Screening costs associated with donor selection for fecal microbiota transplantation for treatment of PD-1 refractory melanoma patients
10. Association Between Facility Surgical Volume and Excess Time in the Hospital After Surgical Resection of Vestibular Schwannomas
11. Use of a Novel Clinical Decision-Making Tool in Vestibular Schwannoma Treatment
12. Machine Learning to Predict Hearing Preservation After Middle Cranial Fossa Approach for Sporadic Vestibular Schwannomas
13. Real World Outcomes for AYA Patients with Relapsed/Refractory B-Cell ALL Receiving CD19-Directed CAR T-Cell Therapy
14. Assessment of Central Nervous System Responses in Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Receiving Brexucabtagene Autoleucel As an FDA-Approved Standard of Care
15. LES ESPÈCES ET LA MONNAIE: quels enjeux et perspectives pour demain?
16. Knowledge, cultural, and attitudinal barriers to mammography screening among nonadherent immigrant Chinese women: ever versus never screened status
17. Framework for in vivo T cell screens
18. Mexico
19. Analysis of Hearing Preservation in Middle Cranial Fossa Resection of Vestibular Schwannoma
20. Delayed Facial Nerve Palsy Following Resection of Vestibular Schwannoma: Clinical and Surgical Characteristics
21. Venetoclax and azacitidine followed by allogeneic transplant results in excellent outcomes and may improve outcomes versus maintenance therapy among newly diagnosed AML patients older than 60
22. Opioid Prescribing Patterns After Skull Base Surgery for Vestibular Schwannoma
23. Mexico
24. Mexican Congress passes extensive tax reform package.
25. Start-up sports leagues: why these leagues are entitled to use the ruinous competition defense to justify anticompetitive restraints.
26. Mexico's inflation adjustment on monetary assets and liabilities.
27. Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2: testing among Ashkenazi Jewish women
28. Mexican taxation of flow-through vehicles.
29. Mexico's three-part tax reform plan goes to Congress.
30. Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia
31. Cochlear T2 Signal May Predict Hearing Outcomes After Resection of Acoustic Neuroma
32. The Relationship Between the Functional Gait Assessment and Quality-of-Life Data in Patients Undergoing Vestibular Schwannoma Resection
33. The Impact of Social Determinants of Health on Brexucabtagene Autoleucel Outcomes in Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
34. Selective Use of the Retrosigmoid Approach for Acoustic Neuroma
35. Surgical Resection of Vestibular Schwannomas After Failed Irradiation
36. Temporal Lobe Changes following Middle Fossa Craniotomy: Clinical Significance
37. Incidence and Clinical Characteristics of Acoustic Neuroma in Beverly Hills
38. Outcomes of Haplo-Cord Versus Dual Cord Transplants: A Single-Center Retrospective Analysis
39. Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL
40. Mexican tax credit for technological research and development projects.
41. An examination of the Mexican tax reform proposals for 2005.
42. New approaches to the treatment of older adults with acute lymphoblastic leukemia
43. Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer.
44. Discordance between Next Generation Sequencing and BCR-ABL PCR Measurable Residual Disease in Adult Patients with Ph+ Acute Lymphoblastic Leukemia
45. Age-Adapted Chemotherapy for Adults >40 Years Old with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: Single Center Outcomes
46. Bridging Therapy in Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Receiving Standard of Care Brexucabtagene Autoleucel: Results from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA)
47. Retrospective Analysis of Adolescent Young Adult Patients with Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Treated with the CALGB 10403 Regimen Since Completion of Trial Enrollment
48. Digital Health Literacy in Patients with Non-Hodgkin Lymphoma: Informing Intervention Approaches to Address Financial Toxicity
49. The Impact of Social Determinants of Health on Brexucabtagene Autoleucel Outcomes in Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
50. Toxicity Profile of Brexucabtagene Autoleucel (brexu-cel; CD19-directed CAR T-cell therapy) in Adult Patients (pts) with Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL): Results from a Multicenter Real-World Outcomes Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.